MRVL
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Supports a bullish reading. 7 purchase disclosures year to date
- Financial indicators Supports a bullish reading. Current ratio 2.01 · operating margin 16%
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
VENTE TOTALE: 15 000 titres (~3 446 025,00 $ US)
- Insiders
- MURPHY MATTHEW J
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$3,446,025
Avg sell (VWAP, 90d window) $216.20 vs last close $261.94 (+21.2%)
- Last activity
- 2026-09-15
- Liquidity
- Liquid $5,253,159,184/day · 20d vol
- Last synced
-
2026-09-25 21:10:41
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-15 | MURPHY MATTHEW J | Sell | 7,500 | $223.39 | $1,675,425 | Form 4 |
| 2026-08-17 | MURPHY MATTHEW J | Sell | 7,500 | $236.08 | $1,770,600 | Form 4 |
| 2026-07-16 | Bharathi Sandeep | Sell | 9,013 | $199.24 | $1,795,750 | Form 4 |
| 2026-07-15 | MURPHY MATTHEW J | Sell | 7,500 | $209.52 | $1,571,400 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-21
MRVL exhibits strong financial health with solid liquidity (80) and improving fundamentals (85), underpinned by a meaningful FY2026 profitability turnaround and successful deleveraging.
The first sentence of the analysis written for MRVL on 2026-09-21 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 51.0% | 41.3% | 41.6% | 50.5% | 46.3% | |
| Ebit Margin | 39.7% | -12.2% | -9.9% | 4.3% | -7.7% | |
| Ebitda Margin | 55.4% | 11.3% | 15.4% | 27.8% | 20.2% | |
| Operating Profit Margin | 16.3% | -12.5% | -10.3% | 4.0% | -7.8% | |
| Pretax Profit Margin | 37.2% | -15.5% | -13.8% | 1.4% | -10.8% | |
| Continuous Operations Profit Margin | 32.6% | -15.3% | -16.9% | -2.8% | -9.4% | |
| Net Profit Margin | 32.6% | -15.3% | -16.9% | -2.8% | -9.4% | |
| Bottom Line Profit Margin | 32.6% | -15.3% | -16.9% | -2.8% | -9.4% | |
| Current Ratio | 2.006 | 1.540 | 1.688 | 1.375 | 1.796 | |
| Quick Ratio | 1.575 | 1.031 | 1.212 | 0.927 | 1.277 | |
| Solvency Ratio | 0.497 | 0.070 | 0.073 | 0.178 | 0.129 | |
| Cash Ratio | 0.819 | 0.468 | 0.524 | 0.382 | 0.442 | |
| Price To Earnings Ratio | 25.458 | -110.647 | -62.685 | -227.105 | -134.717 | |
| Price To Earnings Growth Ratio | -0.063 | 19.916 | -0.134 | 3.540 | -4.603 | |
| Forward Price To Earnings Growth Ratio | -0.063 | 19.916 | -0.134 | 3.540 | -4.603 | |
| Price To Earnings Diluted Ratio | 25.707 | -110.647 | -62.685 | -227.105 | -134.717 | |
| Price To Earnings Diluted Growth Ratio | -0.064 | 19.916 | -0.134 | 3.540 | -4.603 | |
| Price To Book Ratio | 4.749 | 7.275 | 3.932 | 2.349 | 3.623 | |
| Price To Sales Ratio | 8.292 | 16.937 | 10.587 | 6.206 | 12.750 | |
| Price To Free Cash Flow Ratio | 48.661 | 70.294 | 57.150 | 34.286 | 89.968 | |
| Price To Operating Cash Flow Ratio | 38.818 | 58.102 | 42.547 | 28.506 | 69.444 | |
| Debt To Assets Ratio | 0.215 | 0.215 | 0.207 | 0.210 | 0.214 | |
| Debt To Equity Ratio | 0.335 | 0.323 | 0.297 | 0.303 | 0.301 | |
| Debt To Capital Ratio | 0.251 | 0.244 | 0.229 | 0.233 | 0.231 | |
| Long Term Debt To Capital Ratio | 0.217 | 0.227 | 0.215 | 0.200 | 0.222 | |
| Financial Leverage Ratio | 1.557 | 1.505 | 1.431 | 1.440 | 1.408 | |
| Working Capital Turnover Ratio | 3.782 | 4.925 | 5.140 | 5.922 | 5.426 | |
| Operating Cash Flow Ratio | 0.544 | 0.829 | 0.755 | 0.540 | 0.590 | |
| Operating Cash Flow Sales Ratio | 0.214 | 0.292 | 0.249 | 0.218 | 0.184 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.798 | 0.827 | 0.744 | 0.831 | 0.772 | |
| Debt Service Coverage Ratio | 5.927 | 2.074 | 2.119 | 1.854 | 4.759 | |
| Interest Coverage Ratio | 6.606 | -3.803 | -2.682 | 1.395 | -2.496 | |
| Short Term Operating Cash Flow Coverage Ratio | 3.502 | 12.982 | 12.773 | 2.205 | 12.964 | |
| Operating Cash Flow Coverage Ratio | 0.365 | 0.387 | 0.311 | 0.272 | 0.173 | |
| Capital Expenditure Coverage Ratio | 4.944 | 5.765 | 3.913 | 5.931 | 4.384 | |
| Dividend Paid And Capex Coverage Ratio | 3.130 | 3.368 | 2.461 | 3.056 | 2.168 | |
| Dividend Payout Ratio | 0.077 | -0.234 | -0.222 | -1.250 | -0.454 | |
| Enterprise Value Multiple | 15.442 | 155.118 | 72.600 | 24.614 | 67.704 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 51.0% | ▲9.7% | ▲4.9% |
| Ebit Margin | 39.6% | ▲51.9% | ▲36.8% |
| Ebitda Margin | 55.4% | ▲44.1% | ▲29.4% |
| Operating Profit Margin | 16.3% | ▲28.8% | ▲18.4% |
| Pretax Profit Margin | 37.2% | ▲52.7% | ▲37.5% |
| Continuous Operations Profit Margin | 32.6% | ▲47.9% | ▲35.0% |
| Net Profit Margin | 32.6% | ▲47.9% | ▲35.0% |
| Bottom Line Profit Margin | 32.6% | ▲47.9% | ▲35.0% |
| Current Ratio | 2.006 | ▲0.467 | ▲0.325 |
| Quick Ratio | 1.575 | ▲0.544 | ▲0.371 |
| Solvency Ratio | 0.496 | ▲0.427 | ▲0.307 |
| Cash Ratio | 0.819 | ▲0.351 | ▲0.292 |
| Price To Earnings Ratio | 25.458 | ▲136.105 | ▲127.397 |
| Price To Earnings Growth Ratio | -0.063 | ▼-19.980 | ▼-3.794 |
| Forward Price To Earnings Growth Ratio | -0.063 | ▼-19.980 | ▼-3.794 |
| Price To Earnings Diluted Ratio | 25.707 | ▲136.354 | ▲127.596 |
| Price To Earnings Diluted Growth Ratio | -0.064 | ▼-19.981 | ▼-3.795 |
| Price To Book Ratio | 4.749 | ▼-2.526 | ▲0.363 |
| Price To Sales Ratio | 8.292 | ▼-8.645 | ▼-2.662 |
| Price To Free Cash Flow Ratio | 48.661 | ▼-21.633 | ▼-11.411 |
| Price To Operating Cash Flow Ratio | 38.818 | ▼-19.284 | ▼-8.665 |
| Debt To Assets Ratio | 0.215 | -0.000 | ▲0.003 |
| Debt To Equity Ratio | 0.335 | ▲0.011 | ▲0.023 |
| Debt To Capital Ratio | 0.251 | ▲0.006 | ▲0.013 |
| Long Term Debt To Capital Ratio | 0.217 | ▼-0.009 | ▲0.001 |
| Financial Leverage Ratio | 1.558 | ▲0.053 | ▲0.089 |
| Working Capital Turnover Ratio | 3.782 | ▼-1.143 | ▼-1.257 |
| Operating Cash Flow Ratio | 0.543 | ▼-0.286 | ▼-0.108 |
| Operating Cash Flow Sales Ratio | 0.214 | ▼-0.078 | ▼-0.017 |
| Free Cash Flow Operating Cash Flow Ratio | 0.798 | ▼-0.029 | ▲0.003 |
| Debt Service Coverage Ratio | 5.927 | ▲3.854 | ▲2.581 |
| Interest Coverage Ratio | 6.606 | ▲10.409 | ▲6.802 |
| Short Term Operating Cash Flow Coverage Ratio | 3.502 | ▼-9.480 | ▼-5.383 |
| Operating Cash Flow Coverage Ratio | 0.365 | ▼-0.022 | ▲0.064 |
| Capital Expenditure Coverage Ratio | 4.944 | ▼-0.822 | ▼-0.044 |
| Dividend Paid And Capex Coverage Ratio | 3.130 | ▼-0.238 | ▲0.294 |
| Dividend Payout Ratio | 0.077 | ▲0.311 | ▲0.493 |
| Enterprise Value Multiple | 15.442 | ▼-139.677 | ▼-51.654 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $67.95B | $97.68B | $58.31B | $36.74B | $56.90B | |
| Enterprise value | $70.10B | $101.08B | $61.76B | $40.56B | $61.01B | |
| EV / Sales | 8.55x | 17.53x | 11.21x | 6.85x | 13.67x | |
| EV / Op. cash flow | 40.05x | 60.12x | 45.06x | 31.48x | 74.46x | |
| EV / Free cash flow | 50.20x | 72.74x | 60.53x | 37.86x | 96.47x | |
| EV / EBITDA | 15.44x | 155.12x | 72.60x | 24.61x | 67.70x | |
| Net debt / EBITDA | 0.47x | 5.21x | 4.06x | 2.32x | 4.56x | |
| Current ratio | 2.01x | 1.54x | 1.69x | 1.38x | 1.80x | |
| Income quality | 0.66x | -1.90x | -1.47x | -7.88x | -1.95x | |
| Graham number | $34 | — | — | — | — | |
| Graham net-net | -$3 | -$5 | -$5 | -$5 | -$6 | |
| Tax burden | 87.6% | 98.9% | 123.0% | -192.1% | 87.1% | |
| Interest burden | 93.8% | 126.9% | 138.7% | 33.3% | 140.5% | |
| Working capital | $3.24B | $1.09B | $1.25B | $894.4M | $1.10B | |
| Invested capital | $17.57B | $16.83B | $18.15B | $18.81B | $19.86B | |
| Return on assets | 12.0% | -4.4% | -4.4% | -0.7% | -1.9% | |
| Operating ROA | 6.3% | -3.5% | -2.6% | 1.1% | -2.1% | |
| Return on tangible assets | 29.1% | -16.1% | -17.7% | -3.0% | -10.6% | |
| Return on equity | 18.7% | -6.6% | -6.3% | -1.0% | -2.7% | |
| Return on invested capital | 6.0% | -3.9% | -2.9% | -2.2% | -1.5% | |
| Return on capital employed | 7.0% | -4.0% | -2.9% | 1.2% | -1.7% | |
| Earnings yield | 3.9% | -0.9% | -1.6% | -0.4% | -0.7% | |
| Free cash flow yield | 2.1% | 1.4% | 1.7% | 2.9% | 1.1% | |
| Capex / Op. cash flow | 20.2% | 17.3% | 25.6% | 16.9% | 22.8% | |
| Capex / Depreciation | 27.4% | 21.5% | 25.1% | 15.6% | 15.0% | |
| Capex / Sales | 4.3% | 5.1% | 6.4% | 3.7% | 4.2% | |
| SG&A / Sales | 9.4% | 13.8% | 15.1% | 14.3% | 21.4% | |
| R&D / Sales | 25.3% | 33.8% | 34.4% | 30.1% | 31.9% | |
| Stock comp / Sales | 7.2% | 10.4% | 11.1% | 9.3% | 10.3% | |
| Intangibles / Total assets | 58.8% | 72.8% | 75.1% | 76.1% | 82.1% | |
| Days sales outstanding | 97d | 65d | 74d | 74d | 86d | |
| Days payables outstanding | 98d | 67d | 47d | 58d | 70d | |
| Operating cycle | 224d | 176d | 172d | 206d | 195d | |
| Cash conversion cycle | 126d | 109d | 126d | 149d | 125d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-08-07 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
| 2026-07-17 | Gilbert Cisneros | Buy | $1,001 - $15,000 | Filing |
| 2026-07-16 | Gilbert Cisneros | Buy | $1,001 - $15,000 | Filing |
| 2026-07-07 | Ro Khanna | Buy | $15,001 - $50,000 | Filing |
| 2026-06-05 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-08-07 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-07-17 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2026-07-07 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2026-06-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-04-06 | Maria Elvira Salazar | Purchase | $15,001 - $50,000 |
| 2026-04-02 | Byron Donalds | Purchase | $1,001 - $15,000 |
| 2026-04-02 | Byron Donalds | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Val Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres | Sale (Full) | $1,001 - $15,000 |
| 2025-07-03 | James Comer | Sale (Partial) | $1,001 - $15,000 |
| 2025-06-06 | Ritchie Torres | Purchase | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve | Sale (Full) | $50,001 - $100,000 |
| 2025-05-08 | Jefferson Shreve | Sale (Partial) | $15,001 - $50,000 |
| 2025-04-07 | Jefferson Shreve | Purchase | $50,001 - $100,000 |
| 2025-03-05 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-02-20 | Val Hoyle | Purchase | $1,001 - $15,000 |
| 2025-01-21 | James Comer | Purchase | $1,001 - $15,000 |
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-03-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-11-10 | John James | Purchase | $1,001 - $15,000 |
| 2023-10-26 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-06-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-18 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-01-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-01-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-11-30 | Susie Lee | Sale (Full) | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-27 | Ron Estes | Sale (Full) | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-02-10 | Ron Estes | Purchase | $1,001 - $15,000 |
| 2021-11-15 | Bob Gibbs | Sale (Full) | $15,001 - $50,000 |
| 2021-06-09 | Thomas Suozzi | Purchase | $1,001 - $15,000 |
| 2021-06-04 | Thomas Suozzi | Sale (Partial) | $1,001 - $15,000 |
| 2021-06-04 | Thomas Suozzi | Sale (Full) | $1,001 - $15,000 |
| 2021-05-05 | Thomas Suozzi | Purchase | $1,001 - $15,000 |
| 2021-04-21 | Susie Lee | Exchange | $0 - $1,000 |
| 2021-03-01 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2021-02-09 | Susie Lee | Sale (Partial) | $1,001 - $15,000 |
| 2020-12-18 | Thomas Suozzi | Purchase | $1,001 - $15,000 |
| 2020-11-19 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2019-11-08 | Susie Lee | Purchase | $1,001 - $15,000 |
| 2019-11-05 | Bob Gibbs | Purchase | $1,001 - $15,000 |
| 2019-10-04 | Susie Lee | Purchase | $1,001 - $15,000 |
Recent news
- 2026-09-20 3 AI Stocks to Buy Before the Next Fed Rate Decision These AI infrastructure stocks could stay resilient even if rates stay higher.
- 2026-09-19 Prediction: This Nvidia-Backed Artificial Intelligence (AI) Stock Could 10X by 2033 Nvidia CEO Jensen Huang has predicted that Marvell will be the next trillion-dollar stock. Marvell could be on the verge of enormous growth thanks to demand for custom silicon from AI hyperscalers.
- 2026-09-19 Our Top 10 High Growth Dividend Stocks - September 2026 The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 500 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum and is suitable for investors in the accumulation phase.
- 2026-09-19 3 Stocks to Buy Before Wall Street Catches On Before September Ends A chipmaker and two power producers are raising forecasts and signing hyperscaler contracts while their stocks sit well off their peaks. That gap between fundamentals and price action may not last past September.
- 2026-09-18 Wall Street analyst sets Marvell (MRVL) stock price target for 12 months As Marvell Technology, Inc. (NASDAQ: MRVL) stock fell by more than 5% over the past 30 days through September 18, 2026, Joseph Moore, a Wall Street analyst at Morgan Stanley (NYSE: MS), expects less upside over the next 12 months.
- 2026-09-18 GlobalFoundries Jumps 7% on an Expanded Marvell Agreement GlobalFoundries Inc. (GFS) rose 7.04% and Marvell Technology Inc. (MRVL) 5.44% intraday after the two expanded an agreement to increase production capacity for
- 2026-09-18 Breakfast News: Week in Review The Fed hiked to 4%, Generac jumped 40% on Amazon warrants, and more
- 2026-09-17 Marvel Biosciences Provides Update on Private Placement for up to $3.0 Million Calgary, Alberta--(Newsfile Corp. - September 17, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") announced today that, further to its July 16, 2026, August 19, 2026 and September 9, 2026 press releases, it intends to complete a non‐brokered private placement offering (the "Offering") of units of the Company ("Units") at a price of $0.15 per Unit. The Offering will be for a minimum of 10,000,000 Units for gross proceeds of $1,500,000, and up to a maximum of 20,000,000 Units, for gross proceeds of up to $3,000,000.
- 2026-09-17 Buy Marvell, Trim Nvidia: Dale Smothers'' Moves to Make Now Thanks to GoDaddy for sponsoring this video. Head to https://godaddy.yt.link/UUZbVSW to start using GoDaddy Airo AI Builder with 50 free credits.
- 2026-09-17 GlobalFoundries and Marvell expand SiGe deal for AI data centers Globalfoundries Inc (NASDAQ:GFS) and Marvell Technology Inc (NASDAQ:MRVL) expanded their multiyear manufacturing agreement to increase semiconductor production capacity as growing AI data centers fuel demand for faster optical connections. The agreement will boost production capacity at GlobalFoundries'' Burlington, Vermont, facility for silicon germanium technology, known as SiGe, which enables faster and more energy-efficient semiconductor devices.